398 related articles for article (PubMed ID: 27477080)
21. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiome, liver immunology, and liver diseases.
Wang R; Tang R; Li B; Ma X; Schnabl B; Tilg H
Cell Mol Immunol; 2021 Jan; 18(1):4-17. PubMed ID: 33318628
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiota and Liver Injury (II): Chronic Liver Injury.
Baker SS; Baker RD
Adv Exp Med Biol; 2020; 1238():39-54. PubMed ID: 32323179
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and liver diseases.
Minemura M; Shimizu Y
World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
[TBL] [Abstract][Full Text] [Related]
25. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
de Faria Ghetti F; Oliveira DG; de Oliveira JM; de Castro Ferreira LEVV; Cesar DE; Moreira APB
Eur J Nutr; 2018 Apr; 57(3):861-876. PubMed ID: 28875318
[TBL] [Abstract][Full Text] [Related]
26. Role of Gut Microbiota in Liver Disease.
Brenner DA; Paik YH; Schnabl B
J Clin Gastroenterol; 2015; 49 Suppl 1(0 1):S25-7. PubMed ID: 26447960
[TBL] [Abstract][Full Text] [Related]
27. Microbiome and bacterial translocation in cirrhosis.
Gómez-Hurtado I; Such J; Francés R
Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
[TBL] [Abstract][Full Text] [Related]
28. Targeting the gut-liver axis in liver disease.
Wiest R; Albillos A; Trauner M; Bajaj JS; Jalan R
J Hepatol; 2017 Nov; 67(5):1084-1103. PubMed ID: 28526488
[TBL] [Abstract][Full Text] [Related]
29. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang L; Schnabl B
Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750
[TBL] [Abstract][Full Text] [Related]
30. Role of γδT cells in liver diseases and its relationship with intestinal microbiota.
Zhou QH; Wu FT; Pang LT; Zhang TB; Chen Z
World J Gastroenterol; 2020 May; 26(20):2559-2569. PubMed ID: 32523311
[TBL] [Abstract][Full Text] [Related]
31. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
[TBL] [Abstract][Full Text] [Related]
32. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
[TBL] [Abstract][Full Text] [Related]
34. Probiotics and Liver Disease: Where Are We Now and Where Are We Going?
Elzouki AN
J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S188-S190. PubMed ID: 27741172
[TBL] [Abstract][Full Text] [Related]
35. Liver-Microbiome Axis in Health and Disease.
Adolph TE; Grander C; Moschen AR; Tilg H
Trends Immunol; 2018 Sep; 39(9):712-723. PubMed ID: 29843959
[TBL] [Abstract][Full Text] [Related]
36. Gut-liver axis: gut microbiota in shaping hepatic innate immunity.
Wu X; Tian Z
Sci China Life Sci; 2017 Nov; 60(11):1191-1196. PubMed ID: 28840534
[TBL] [Abstract][Full Text] [Related]
37. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
38. The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.
van Best N; Jansen PL; Rensen SS
Hepatol Int; 2015 Jul; 9(3):406-15. PubMed ID: 26067771
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
40. The gut microbiota and the liver: implications for clinical practice.
Quigley EM; Monsour HP
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):723-32. PubMed ID: 24134195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
